An imbalance in the Bax/Bcl-2 ratio, which tips the scales towards survival, can make tumor cells more resistant to a variety of cell death stimuli, including all chemotherapeutic agents, radiation, hypoxia, or growth factor deprivation [71]. The gene discussed is BCL2; the disease is neoplasm.